What type of study is this?

This is a Literature Review study.

August 21, 2025Journal of Clinical MedicineOpen Access

Heart Failure Readmission Prevention Strategies—A Comparative Review of Medications, Devices, and Other Interventions

View Full Paper

Ask AI

Bookmark

Heart failure readmission rates remain high, especially within 30 days of discharge, causing significant health challenges.
Pharmacological therapies like diuretics and beta-blockers showed promise in reducing readmission rates in clinical studies.
A comparative review of device-based interventions—like CardioMEMS and LVADs—reveals their importance in managing heart failure.
Multidisciplinary, patient-centered strategies may improve outcomes and significantly lower readmission risks for heart failure patients.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

This review examines heart failure readmission rates and highlights evidence-based interventions to reduce hospitalizations, including medications and devices.

Cite This Study

Baris et al. (2025) studied this question.

synapsesocial.com/papers/68af5095ad7bf08b1ead825a https://doi.org/10.3390/jcm14165894

View Full Paper

Ask AI

Bookmark

Implication

This review examines heart failure readmission rates and highlights evidence-based interventions to reduce hospitalizations, including medications and devices.

Heart Failure Readmission Prevention Strategies—A Comparative Review of Medications, Devices, and Other Interventions

Key Points

Discussion

Implication

Cite This Study

Heart Failure Readmission Prevention Strategies—A Comparative Review of Medications, Devices, and Other Interventions

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider